GlassScriptPhysician profile
Jerome Donald Chao
NPI 1467474866
$5,873.45
in general payments reported to CMS, 2019-2025
17 companies · $1,963 in 2025
The $1,963 reported for 2025 was more than what 84% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,614 · 2020: $392 · 2021: $502 · 2022: $420 · 2023: $263 · 2024: $718 · 2025: $1,963.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,881 · Travel and Lodging: $1,064.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,881.41 |
| Travel and Lodging | $1,063.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,539.84 | 2023-2025 | Natrelle Saline-Filled Breast Implants |
| Allergan, INC. | $1,187.94 | 2019-2022 | |
| Tela Bio, INC. | $733.35 | 2023-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Sientra, INC. | $566.00 | 2019-2020 | |
| Galderma Laboratories, L.P. | $454.69 | 2019-2025 | |
| Mentor Worldwide LLC | $320.41 | 2021-2023 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Merz North America, INC. | $273.59 | 2021-2025 | |
| Musculoskeletal Transplant Foundation INC. | $228.56 | 2020-2024 | |
| Vertex Pharmaceuticals Incorporated | $182.23 | 2025 | |
| Acelrx Pharmaceuticals, INC. | $161.83 | 2021-2022 | |
| Medical Device Business Services, INC. | $95.39 | 2019 | |
| Henry Schein, INC. | $38.93 | 2024 | |
| Novo Nordisk INC | $22.02 | 2022 | |
| Solta Medical, A Division of Bausch Health US, LLC | $19.62 | 2025 | |
| Vertical Pharmaceuticals, LLC | $18.00 | 2023 | Dsuvia |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $16.99 | 2019 | |
| Integra Lifesciences Corporation | $14.06 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerome Chao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.